Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2026 07:00 ET | Source: Antag Therapeutics

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors Copenhagen, Denmark, 09 June 2026 – Antag Therapeutics (“Antag” or “the Company”), advancing personalized and flexible...
June 07, 2026 13:30 ET | Source: Antag Therapeutics

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

AT7687 demonstrated a favorable safety and tolerability profile with no adverse GI tolerability signals identifiedOnce-weekly dosing potential and demonstrated target engagement across the doses...